Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Prof Peter O'Gorman
Mater Misericordiae University Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Aarhus University Hospital
Aarhus, Denmark
- Beaumont Hospital
Dublin, Ireland
- Mater Misericordiae University Hospital
Dublin, Ireland
- St James'S Hospital
Dublin, Ireland
- University Hospital Waterford
Waterford, Ireland
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Apr 2022
- Primary completion
- 24 Jun 2025
- Completion
- 15 Dec 2027
- Last update posted
- 8 Jul 2025
- Registered enrollment
- 54
- Registry id
- NCT05123131
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 30 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.